Download presentation
Presentation is loading. Please wait.
Published byEverett Lloyd Modified over 9 years ago
1
Identification of the First Direct Interaction between Trypanosomes and the Host Immune System Olivia Macleod
3
African sleeping sickness Endemic to sub-Saharan Africa Caused by the parasite Trypanosoma brucei Transmitted by the tsetse fly Lives in the bloodstream of humans and livestock Ineffective treatments Photos: Brun et al. (2010); Prof. Michael Duszenko, Universität Tübingen
4
African sleeping sickness Endemic to sub-Saharan Africa Caused by the parasite Trypanosoma brucei Transmitted by the tsetse fly Lives in the bloodstream of humans and livestock Ineffective treatments Photos: Brun et al. (2010); Prof. Michael Duszenko, Universität Tübingen
5
How does the parasite avoid detection in our bloodstream and destruction by our immune systems?
6
Avoiding the immune system Immune attack 1Immune attack 2 Grey destroyed Yellow survive and multiply Yellow destroyed Red survive and multiply Process continues for many years The parasites constantly change their surface coat
7
How, then, can we target these parasites?
8
Close-up of parasite surface Parasite surface: a weak spot Known surface proteins that take up essential nutrients from the bloodstream Unknown surface proteins
9
Known surface proteins that take up essential nutrients from the bloodstream Unknown surface proteins Close-up of parasite surface Parasite surface: a weak spot
10
Aim of PhD To determine the function of these surface proteins in order to obtain a complete understanding of the molecular interaction between the parasite and the host
11
Identifying novel surface proteins Human and cattle bloodstreamTsetse fly Factor H
12
Importance of discovery Factor H-binding protein is the first discovery of a direct interaction between the host immune system and this parasite Blocking the interaction between Factor H and the parasite may prevent its survival in the host Two additional surface proteins have been discovered that bind components in the bloodstream Factor H
13
Commercial application Progress with company in Cambridge Producing monoclonal antibodies against two trypanosome surface proteins Could lead to a targeted treatment against African sleeping sickness
14
Commercial application Progress with company in Cambridge Monoclonal antibody competes/interferes with Factor H binding Parasite death Factor H
15
Acknowledgements Carrington Lab Members Lab FundingPhD Funding Magdalene College University of Cambridge Cambridge Society for the Application of Research
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.